Tata Power Ltd said it registered its Khandke Wind Farm in Maharashtra with the United Nations Framework Convention on Climate Change (UNFCCC) as a clean development mechanism (CDM) project.
The company’s 50.4MW Khandke Wind Farm was commissioned in December 2007.
The project is expected to earn 85,000 certified emission reductions (CERs) annually from UNFCCC, it said in a regulatory filing.
CDM is an instrument established under the Kyoto Protocol to achieve both sustainable development and contribute to the cost effective mitigation of climate change.
On Wednesday, Tata Power shares closed 0.1% up at Rs1,326 on the Bombay Stock Exchange, while the Sensex ended at 0.3% down at 17,938 points.
Engineering company GEI Industrial Systems Ltd said it won two orders, worth Rs64 crore, from the power sector for the supply of air cooled steam condensers.
The company will set up power plants for Ind-Barath Thermal Power Ltd at Tuticorin in Tamil Nadu. It will also set up a captive power plant for Shree Renuka Sugars Ltd at Gandhidham in Gujarat, it said in a regulatory filing.
On Wednesday, GEI shares closed 0.8% up at Rs132 on the Bombay Stock Exchange, while the Sensex ended at 0.3% down at 17,938 points.
Glenmark Pharmaceutical Ltd said its unit received abbreviated new drug application (ANDA) approval from the US Food and Drug Administration (USFDA) to introduce Theophylline extended-release tablets in the US market.
Theophylline extended-release tablets, used in treatment of chronic asthma and other chronic lung diseases, are the generic version of LP Uniphyl of Purdue Pharmaceutical Products. Glenmark’s extended-release tablets are available in strengths of 400 mg and 600 mg. The company will commence marketing and distribution of this product in the US.
According to IMS Health, Theophylline extended-release tablets had annual sales of $8 million.
On Wednesday, Glenmark shares closed 0.6% up at Rs279 on the Bombay Stock Exchange, while the Sensex ended at 0.3% down at 17,938 points.